ClC1C=C(NC2OC([C@@:14]3(C)[NH:19][C:18](=[NH:20])[N:17](C)C(=O)C3)=NN=2)C=CC=1.[CH3:24]NO.[CH3:27][CH2:28][O-:29].[Na+].[Br:31][C:32]1[CH:33]=C(C(=NC#N)C)[CH:35]=[CH:36][CH:37]=1>C(O)C>[Br:31][C:32]1[CH:33]=[C:27]([C:28]2([CH3:24])[O:29][N:19]([CH3:14])[C:18](=[NH:20])[NH:17]2)[CH:35]=[CH:36][CH:37]=1To a solution of the HCl salt of methylhydroxylamine (0.19 g, 2.2 mmol, 1 eq) in ethanol (25 mL) at 25° C. was added a 21% solution of NaOEt in ethanol (0.75 mL, 2.0 mmol, 0.9 eq) followed by (1-(3-bromophenyl) ethylidene) cyanamide (0.50 g, 2.2 mmol, 1 eq). After stirring at 25° C. for 10 min, the solvent was removed in vacuo. The residue was redissolved in CH2Cl2 (25 mL), the mixture was filtered, and the solvent was removed in vacuo to give 0.5 g (83%) of 5-(3-bromophenyl)-2,5-dimethyl-1,2,4-oxadiazolidin-3-imine (DB2, R1=Me, R4=Me) as a colorless oil: 1H NMR (CDCl3) δ 7.63 (t, J=1.8 Hz, 1H), 7.52. (dd, J=2.0, 1.1 Hz, 1H), 7.38 (dd, J=2.0, 1.1 Hz, 1H), 7.29 (t, J=7.9 Hz, 1H), 3.28 (s, 3H), 1.88 (s, 3H). MS (ESI) m/e 270.0, 272.0 (M+H)+.